BETA-ADRENOCEPTOR AND POSTRECEPTOR COMPONENTS SHOW DIFFERENT RATES OF DESENSITIZATION TO DESIPRAMINE

被引:15
作者
TIONG, AHK
RICHARDSON, JS
机构
[1] UNIV SASKATCHEWAN,DEPT PHARMACOL,SASKATOON S7N 0W0,SASKATCHEWAN,CANADA
[2] UNIV SASKATCHEWAN,DEPT PSYCHIAT,SASKATOON S7N 0W0,SASKATCHEWAN,CANADA
来源
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION | 1990年 / 188卷 / 06期
关键词
ANTIDEPRESSANTS; DESIPRAMINE; ADENYLYL CYCLASE; BETA-ADRENOCEPTORS; BRAIN; (RAT);
D O I
10.1016/0922-4106(90)90203-A
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Both 3-day and 15-day desipramine treatments (10 mg/kg, once daily) significantly reduced beta-1- but not beta-2-adrenoceptor and isoproterenol-stimulated adenylyl cyclase activities in rat cortical, hippocampal and amygdaloid membrane preparations. In contrast, 15-day but not 3-day desipramine treatment resulted in a significant reduction in NaF-, GppNHp- and forskolin-stimulated adenylyl cyclase activity. The results suggest that post-beta-adrenoceptor component desensitization occurs more slowly than receptor downregulation in response to desipramine.
引用
收藏
页码:411 / 415
页数:5
相关论文
共 10 条
[1]  
ANDERSEN PH, 1984, ACTA PHARMACOL TOX, V55, P278
[2]  
HENINGER GR, 1987, PSYCHOPHARMACOLOGY 3, P535
[3]   GUANOSINE TRIPHOSPHATE ACTIVATION OF BRAIN ADENYLATE-CYCLASE - ENHANCEMENT BY LONG-TERM ANTI-DEPRESSANT TREATMENT [J].
MENKES, DB ;
RASENICK, MM ;
WHEELER, MA ;
BITENSKY, MW .
SCIENCE, 1983, 219 (4580) :65-67
[4]   LIGAND - A VERSATILE COMPUTERIZED APPROACH FOR CHARACTERIZATION OF LIGAND-BINDING SYSTEMS [J].
MUNSON, PJ ;
RODBARD, D .
ANALYTICAL BIOCHEMISTRY, 1980, 107 (01) :220-239
[5]   CHRONIC ANTIDEPRESSANT ADMINISTRATION ALTERS THE SUBCELLULAR-DISTRIBUTION OF CYCLIC AMP-DEPENDENT PROTEIN-KINASE IN RAT FRONTAL-CORTEX [J].
NESTLER, EJ ;
TERWILLIGER, RZ ;
DUMAN, RS .
JOURNAL OF NEUROCHEMISTRY, 1989, 53 (05) :1644-1647
[6]   POST-RECEPTOR-MEDIATED INCREASES IN ADENYLATE-CYCLASE ACTIVITY AFTER CHRONIC ANTIDEPRESSANT TREATMENT - RELATIONSHIP TO RECEPTOR DESENSITIZATION [J].
NEWMAN, ME ;
LERER, B .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 162 (02) :345-352
[7]  
OKADA F, 1986, J NEUROCHEM, V47, P454
[8]  
PAUL IA, 1988, J PHARMACOL EXP THER, V246, P956
[9]  
RIVA MA, 1989, MOL PHARMACOL, V36, P211
[10]  
WOLFE BB, 1978, J PHARMACOL EXP THER, V207, P446